hlt-gaming062320-01

The game, called EndeavorRx, will be prescription only and used alongside other treatments, such as clinician-directed therapy, medication and educational programs. — Akili Interactive/Business Wire

The first video game-based treatment for attention deficit hyperactivity disorder (ADHD) has been approved by the US Food and Drug Administration (FDA).

The video game, called EndeavorRx and approved on Monday, will be prescription only and aimed at children between the ages of eight and 12 with certain types of ADHD.

It will be used alongside other treatments, such as clinician-directed therapy, medication and educational programs.

Support The Philadelphia Tribune

Now, more than ever, the world needs trustworthy reporting—but good journalism isn’t free. Please support the nation's longest continuously published newspaper serving the African American community by making a contribution.

ADHD is a common neurodevelopmental disorder which is usually first diagnosed in children and can last into adulthood.

Approximately 4 million children aged six to 11 are affected by ADHD, the symptoms of which include difficulty staying focused and paying attention and difficulty controlling behavior.

This is the first game-based therapy to be granted marketing authorization by the FDA for any condition, the agency said.

"The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics," Dr Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in a press release.

The game, which can be downloaded as an app onto a mobile device, was authorized for marketing after the FDA reviewed five clinical studies that included more than 600 children.

The agency noted that some negative effects were reported, such as frustration, headache, dizziness, emotional reaction and aggression, but said there were no "serious" adverse effects reported.

While playing the game, children steer an avatar through a course dotted with obstacles, collecting targets to earn rewards.

Akili, the company that created EndeavorRx, has said that children should interact with the game 30 minutes per day, five days a week over the course of a one-month treatment cycle.

A representative for Akili said that the game was shown to improve attention function in the target population.

"We're proud to make history today with FDA's decision," said Eddie Martucci, CEO of Akili, in a press release from the organization.

CNN

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.